87 related articles for article (PubMed ID: 21567054)
1. The effects of retinoic Acid analogs on the blast cells of acute myeloblastic-leukemia in culture.
Tohda S; Shudo K; Minden M
Int J Oncol; 1994 Jun; 4(6):1311-4. PubMed ID: 21567054
[TBL] [Abstract][Full Text] [Related]
2. Constitutive expression of cellular retinoic acid binding protein II and lack of correlation with sensitivity to all-trans retinoic acid in acute promyelocytic leukemia cells.
Zhou DC; Hallam SJ; Lee SJ; Klein RS; Wiernik PH; Tallman MS; Gallagher RE
Cancer Res; 1998 Dec; 58(24):5770-6. PubMed ID: 9865735
[TBL] [Abstract][Full Text] [Related]
3. Specific uptake of retinoids into human promyelocytic leukemia cells HL-60 by retinoid-specific binding protein: possibly the true retinoid receptor.
Hashimoto Y; Kagechika H; Kawachi E; Shudo K
Jpn J Cancer Res; 1988 Apr; 79(4):473-83. PubMed ID: 2838445
[TBL] [Abstract][Full Text] [Related]
4. Induction of differentiation and covalent binding to proteins by the synthetic retinoids Ch55 and Am80.
Takahashi N; Breitman TR
Arch Biochem Biophys; 1994 Oct; 314(1):82-9. PubMed ID: 7944409
[TBL] [Abstract][Full Text] [Related]
5. In vitro all-trans retinoic acid (ATRA) sensitivity and cellular retinoic acid binding protein (CRABP) levels in relapse leukemic cells after remission induction by ATRA in acute promyelocytic leukemia.
Cornic M; Delva L; Castaigne S; Lefebvre P; Balitrand N; Degos L; Chomienne C
Leukemia; 1994; 8 Suppl 2():S16-9. PubMed ID: 7815831
[TBL] [Abstract][Full Text] [Related]
6. In vitro all-trans retinoic acid (ATRA) sensitivity and cellular retinoic acid binding protein (CRABP) levels in relapse leukemic cells after remission induction by ATRA in acute promyelocytic leukemia.
Cornic M; Delva L; Castaigne S; Lefebvre P; Balitrand N; Degos L; Chomienne C
Leukemia; 1994 Jun; 8(6):914-7. PubMed ID: 8207983
[TBL] [Abstract][Full Text] [Related]
7. Anticoagulant effects of synthetic retinoids and activated vitamin D3.
Koyama T; Hirosawa S
Semin Thromb Hemost; 1998; 24(3):217-26. PubMed ID: 9701451
[TBL] [Abstract][Full Text] [Related]
8. [Mechanism of action of retinoids in a new therapeutic approach to acute promyelocytic leukemia].
Cornic M; Guidez F; Delva L; Agadir A; Degos L; Chomienne C
Bull Cancer; 1992; 79(7):697-704. PubMed ID: 1334741
[TBL] [Abstract][Full Text] [Related]
9. All-Trans Retinoic Acid Activity in Acute Myeloid Leukemia: Role of Cytochrome P450 Enzyme Expression by the Microenvironment.
Su M; Alonso S; Jones JW; Yu J; Kane MA; Jones RJ; Ghiaur G
PLoS One; 2015; 10(6):e0127790. PubMed ID: 26047326
[TBL] [Abstract][Full Text] [Related]
10. All-trans retinoic acid and hematopoietic growth factors regulating the growth and differentiation of blast progenitors in acute promyelocytic leukemia.
Miyauchi J
Leuk Lymphoma; 1999 Apr; 33(3-4):267-80. PubMed ID: 10221506
[TBL] [Abstract][Full Text] [Related]
11. Anticoagulant effects of synthetic retinoids.
Koyama T; Shibakura M
Leuk Lymphoma; 1998 Sep; 31(1-2):71-80. PubMed ID: 9720716
[TBL] [Abstract][Full Text] [Related]
12. Differentiation induction of human promyelocytic leukemia cells by acyclic retinoid (polyprenoic acid).
Tsurumi H; Tojo A; Takahashi T; Ozawa K; Moriwaki H; Asano S; Muto Y
Int J Hematol; 1993 Dec; 59(1):9-15. PubMed ID: 8161738
[TBL] [Abstract][Full Text] [Related]
13. Granulocytic differentiation of human NB4 promyelocytic leukemia cells induced by all-trans retinoic acid metabolites.
Idres N; Benoît G; Flexor MA; Lanotte M; Chabot GG
Cancer Res; 2001 Jan; 61(2):700-5. PubMed ID: 11212271
[TBL] [Abstract][Full Text] [Related]
14. Common defects of different retinoic acid resistant promyelocytic leukemia cells are persistent telomerase activity and nuclear body disorganization.
Nason-Burchenal K; Maerz W; Albanell J; Allopenna J; Martin P; Moore MA; Dmitrovsky E
Differentiation; 1997 Aug; 61(5):321-31. PubMed ID: 9342843
[TBL] [Abstract][Full Text] [Related]
15. N-4-hydroxyphenylretinamide enhances retinoic acid-induced differentiation and retinoylation of proteins in the human acute promyelocytic leukemia cell line, NB4, by a mechanism that may involve inhibition of retinoic acid catabolism.
Taimi M; Breitman TR
Biochem Biophys Res Commun; 1997 Mar; 232(2):432-6. PubMed ID: 9125196
[TBL] [Abstract][Full Text] [Related]
16. Benzodithiophenes potentiate differentiation of acute promyelocytic leukemia cells by lowering the threshold for ligand-mediated corepressor/coactivator exchange with retinoic acid receptor alpha and enhancing changes in all-trans-retinoic acid-regulated gene expression.
Xu K; Guidez F; Glasow A; Chung D; Petrie K; Stegmaier K; Wang KK; Zhang J; Jing Y; Zelent A; Waxman S
Cancer Res; 2005 Sep; 65(17):7856-65. PubMed ID: 16140955
[TBL] [Abstract][Full Text] [Related]
17. Retinoic acid-induced expression of CD38 antigen in myeloid cells is mediated through retinoic acid receptor-alpha.
Drach J; McQueen T; Engel H; Andreeff M; Robertson KA; Collins SJ; Malavasi F; Mehta K
Cancer Res; 1994 Apr; 54(7):1746-52. PubMed ID: 7511050
[TBL] [Abstract][Full Text] [Related]
18. Acute promyelocytic leukemia and differentiation therapy: molecular mechanisms of differentiation, retinoic acid resistance and novel treatments.
Özpolat B
Turk J Haematol; 2009 Jun; 26(2):47-61. PubMed ID: 27265273
[TBL] [Abstract][Full Text] [Related]
19. Rosmarinic acid potentiates ATRA-induced macrophage differentiation in acute promyelocytic leukemia NB4 cells.
Heo SK; Noh EK; Yoon DJ; Jo JC; Koh S; Baek JH; Park JH; Min YJ; Kim H
Eur J Pharmacol; 2015 Jan; 747():36-44. PubMed ID: 25481858
[TBL] [Abstract][Full Text] [Related]
20. The histone deacetylase inhibitor valproic acid alters sensitivity towards all trans retinoic acid in acute myeloblastic leukemia cells.
Trus MR; Yang L; Suarez Saiz F; Bordeleau L; Jurisica I; Minden MD
Leukemia; 2005 Jul; 19(7):1161-8. PubMed ID: 15902297
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
